White Papers

1. How Sponsors Are Responding To FDA's RTCT Request For Information 9/9/2026

   Let's take a look at where continuous, real-time regulatory review can meaningfully speed drug development, and where it likely won't help much.

2. Developing Next-Generation Therapies For Breast Cancer Patients 9/8/2026

   Breast cancer trials span multiple subtypes and modalities. Learn how specialized oncology experience helps reduce enrollment risk and keep programs on track.

3. Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development 9/8/2026

   Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.

4. Cross-Functional Best Practices For Signal Detection In Special Case Scenarios 9/7/2026

   When trial data fall short, real risk signals surface in inquiries, complaints, and reports. Learn how coordinated, cross-functional practices help catch risk earlier.

5. Trust In AI Agents Has To Be Earned Continuously, Not Just Once 9/7/2026

   This white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.

6. A Practical Guide To Harnessing The Value Of APAC For Global Trial Success 8/21/2026

   As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.

7. Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations 8/20/2026

   Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.

8. Navigating Large-Volume Subcutaneous Biologic Injections 8/12/2026

   Large-volume subcutaneous delivery is bringing biologic treatments closer to patients. Learn how advances in dosing and device technology are shaping care.

9. Flying On Two Wings: Balancing Local Agility And Global Quality In China 8/12/2026

   As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.

10. Matching Pharmacovigilance Methodology To Organizational Scale 8/12/2026

    One-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.